Leading Growth Driver in the Canine Arthritis Treatment Market in 2025: Rising Pet Ownership Rates Drive Growth In Canine Arthritis Treatment Market Driver's Influence

What combination of drivers is leading to accelerated growth in the canine arthritis treatment market?
The canine arthritis treatment market is forecasted to expand due to an increase in pet ownership rates. This concept of pet ownership implies the commitment and care offered by individuals or households for the sustenance, wellness, and companionship of tamed animals cherished primarily for pleasure rather than for their practical uses. A shift in lifestyle, pet humanization, and higher expendable incomes are responsible for the surge in rates of pet ownership. Pet owners employ canine arthritis treatments to minimize and manage their dogs' arthritis symptoms, with the aim to enhance their pet's life quality and retain mobility. For instance, data from the American Pet Products Association, a non-profit association based in the US, showed that in October 2023, there were 86.9 million pet-owning households in the US, which was an increase from 66% of households in 2022. Consequently, the escalating rate of pet ownership is fuelling the expansion of the canine arthritis treatment market.

Get Your Canine Arthritis Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

What is the projected compound annual growth rate (CAGR) of the canine arthritis treatment market from 2025 to 2034, and what factors influence it?
In recent times, the market for canine arthritis treatment has seen vigorous growth. The market, which was valued at $2.35 billion in 2024, is projected to reach $2.48 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. The significant growth in the past period was due to factors such as an increasing aging pet population, better awareness among pet owners, emphasis on preventive care, rising disposable income, and a surge in spending on veterinary care.

In the coming years, robust expansion is projected for the canine arthritis treatment market, with its value expected to hit $3.06 billion by 2029, indicating a compound annual growth rate (CAGR) of 5.4%. This anticipated growth during the prediction period is primarily due to factors such as increasing pet insurance coverage, escalating instances of arthritis, higher pet adoption rates, escalating demand for minimally invasive surgical operations, and the growing occurrence of arthritis in dogs. The upcoming trends for the forecast period encompass innovative treatments, progress in veterinary medicine, the desire for improved therapies, technology integration, and groundbreaking technologies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

How are the latest trends influencing the growth of the canine arthritis treatment market?
Leading businesses in the canine arthritis treatment market are innovating new treatments, such as bedinvetmab injections, to improve canine joint health and mobility. Bedinvetmab, a type of monoclonal antibody injection, functions by targeting and negating the effect of nerve growth factor (NGF) - a protein instrumental in pain mitigation in veterinary medicine. For example, in May 2023, Zoetis Inc., a US-based company specializing in animal health, secured approval from the Food and Drug Administration (FDA) for Librela, a bedinvetmab injection. It distinguished itself as the first monoclonal antibody (mAb) to receive FDA approval for use in dogs. Its function primarily involves binding to and suppressing the biological activity of canine nerve growth factor (NGF), which plays a pivotal part in managing pain linked to osteoarthritis (OA). It is dispensed via a monthly subcutaneous injection, making it a practical and enduring solution for managing pain related to canine OA.

What are the major segments of the canine arthritis treatment market and their role in driving growth?
The canine arthritis treatment market covered in this report is segmented -

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis
4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers
2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements
3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy
4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16007

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the canine arthritis treatment market?
Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill's Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

What Is Covered In The Canine Arthritis Treatment Global Market Report?

•Market Size Forecast: Examine the canine arthritis treatment market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the canine arthritis treatment market for a structured understanding.
•Key Players Overview: Analyze major players in the canine arthritis treatment market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the canine arthritis treatment market.
•Segment Contributions: Evaluate how different segments drive overall growth in the canine arthritis treatment market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the canine arthritis treatment market.
•Industry Challenges: Identify potential risks and obstacles affecting the canine arthritis treatment market.
•Competitive Landscape: Review strategic developments in the canine arthritis treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.